Research Topics
Genomes and GenesSpecies | Kristina Gemzell-DanielssonSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Misoprostol: first-line therapy for incomplete miscarriage in the developing worldK Gemzell-Danielsson
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden
BJOG 114:1337-9. 2007
Emergency contraception -- mechanisms of actionKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
Contraception 87:300-8. 2013..An additional effect on the endometrium as occurs for the Cu-IUD, but not for the hormonal alternatives, seems to increase the efficacy of the method...
Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countriesKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, 17176 Stockholm, Sweden
Contraception 86:631-8. 2012....
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaKristina Gemzell-Danielsson
Division of Obstetrics and Gynecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Fertil Steril 97:616-22.e1-3. 2012..To identify an appropriate dose for a new contraceptive levonorgestrel intrauterine system (LNG-IUS)...
Recent developments in the clinical use of the levonorgestrel-releasing intrauterine systemKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institute Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 90:1177-88. 2011..In treatment of heavy menstrual bleeding, the LNG-IUS appears to be one of the most effective and cost-effective methods...
Comprehensive counseling about combined hormonal contraceptives changes the choice of contraceptive methods: results of the CHOICE program in SwedenKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 90:869-77. 2011..To study the influence of counseling on women's contraceptive decisions...
[Valuable drug for women in poor countries scraped--why?]Kristina Gemzell Danielsson
Karolinska Universitetssjukhuset, Solna
Lakartidningen 103:3901-2. 2006
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and managementKristina Gemzell-Danielsson
Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Reprod Health Matters 16:162-72. 2008..Future studies should focus on improving pain management, the treatment of women with failed medical abortion after 24 hours, and the safety of medical abortion regimens in women with a previous caesarean section or uterine scar...
Mechanism of action of emergency contraceptionKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
Contraception 82:404-9. 2010..LNG-EC has no effect on endometrial development or function. In an in vitro model, it was demonstrated that LNG did not interfere with blastocyst function or implantation...
Studies on uterine contractility following mifepristone and various routes of misoprostolKristina Gemzell-Danielsson
Department of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
Contraception 74:31-5. 2006..Recently, a new oral slow-release preparation of misoprostol has been studied. Future studies will show whether prostaglandin analogues with a prolonged effect on the myometrium may further improve the regimens for medical abortion...
Teaching pelvic examination technique using professional patients: a controlled study evaluating students' skillsKjell Wånggren
Department of Women s and Children s Health, Uppsala University, Akademiska Hospital, Uppsala, Sweden
Acta Obstet Gynecol Scand 89:1298-303. 2010..To compare the skills in pelvic examination technique between students who have had training with professional patients and a control group of students trained using clinical patients...
Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristoneXiaoxi Sun
Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital/Institute, S-171 76, Stockholm, Sweden
Contraception 67:319-26. 2003..These results further support the hypothesis that the contraceptive effect of mifepristone when given postovulatory is primarily due to alteration of the peri-implantation milieu influencing endometrial receptivity...
Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviductXiaoyan Qiu
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
Fertil Steril 80:776-82. 2003....
Measurement of luminal nitric oxide in the uterine cavity using a silicon balloon catheterAngelos Sioutas
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Nitric Oxide 24:213-6. 2011..The levels of nitric oxide are increased in women diagnosed with pelvic inflammatory disease already after an incubation time of 2 min...
Expression of aquaporin-1 in endometrial blood vessels in menorrhagiaMiriam Mints
Department of Clinical Science, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, S 14186 Stockholm, Sweden
Int J Mol Med 19:407-11. 2007..006). Thus, the deregulation of aquaporin-1 in menorrhagia may be involved in abnormal endometrial vascular growth and permeability...
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristoneCaroline Arvidsson
Department of Obstetrics and Gynecology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Eur J Obstet Gynecol Reprod Biol 123:87-91. 2005..CONCLUSION: A majority of women prefer oral administration of misoprostol in early medical abortion...
Aquaporin 1 is expressed in the human endometrium during normal cycle and increases after mifepristone treatmentAnna Hildenbrand
Division of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
Int J Mol Med 22:49-53. 2008..The presence of AQP1 was also confirmed using RT-PCR. The changes in AQP1 expression could contribute to the reduced bleeding seen following mifepristone treatment and could be an effect of either antagonizing progesterone or cortisol...
Medical students learning the pelvic examination: evaluation of a clinical patient modelKjell Wånggren
Department of Women s and Children s Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 89:1304-9. 2010..To evaluate a clinical patient (CP) model for training in pelvic examination...
Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture modelChun Xia Meng
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Fertil Steril 91:256-64. 2009..To investigate the effect of levonorgestrel and mifepristone on the expression of endometrial receptivity markers in a three-dimensional endometrial construct...
Medical abortion in lactating women--low levels of mifepristone in breast milkIngrid Sääv
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 89:618-22. 2010..In addition, serum samples were collected on day 3 (n = 4). Main outcome measures. The levels of mifepristone, quantified using radioimmunoassay...
Expression of aquaporin 2 in human endometriumAnna Hildenbrand
Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
Fertil Steril 86:1452-8. 2006..To study the expression of aquaporin-2 (AQP2) in human endometrium...
Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phaseXiaoxi Sun
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
Fertil Steril 80:1454-60. 2003..The results support a role of epithelial eNOS in human endometrial receptivity...
The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancyAnnette Aronsson
Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Institute, S-171 76 Stockholm, Sweden
Contraception 72:33-9. 2005....
Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicineRebecca Gomperts
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 91:226-31. 2012..Analysis of factors influencing surgical intervention rate after home medical termination of pregnancy (TOP) by women in countries without access to safe services using the telemedical service 'Women on Web'...
Intrauterine nitric oxide in pelvic inflammatory diseaseAngelos Sioutas
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Fertil Steril 89:948-52. 2008..To measure nitric oxide gas directly in the uterus of healthy women and patients with suspected pelvic inflammatory disease...
Effect of emergency contraception with levonorgestrel or mifepristone on ovarian functionLena Marions
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital Institute, 17176 Stockholm, Sweden
Contraception 69:373-7. 2004..This study indicates that, when used for EC, LNG or MIF administered prior to ovulation acts through an impaired ovulatory process and luteal function...
Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endometrium after treatment with mifepristoneXiao Xi Sun
Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
Fertil Steril 85:171-8. 2006..CONCLUSION(S): Treatment with mifepristone has a limited effect on HB-EGF and its receptors in the fallopian tube, while the increase in HER1 and HER4 in the endometrium probably reflects defective endometrial maturation...
Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trialIngrid Sääv
Department of Women s and Children s Health, Division of Obstetrics and Gynaecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
PLoS ONE 7:e48948. 2012..Intrauterine contraceptives (IUC) provide highly effective, reversible, long-acting contraception. However, the effects of timing of IUC insertion after medical abortion are not known...
Effect of letrozole on uterine tonus and contractility: a randomized controlled trialHelena Kopp Kallner
Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, 171 77 Stockholm, Sweden
Contraception 86:419-24. 2012..It has been shown to increase efficacy in medical abortion when used with misoprostol. This study investigated if letrozole acts as an abortifacient due to a synergistic effect with misoprostol on uterine contractility...
Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortionHelena Kopp Kallner
Division of Obstetrics and Gynaecology, Department of Woman and Child Health, Karolinska Institutet Karolinska University Hospital, 171 77 Stockholm, Sweden
Contraception 85:394-7. 2012..The objective of this study was therefore to assess factors affecting acceptability and experience of home use of misoprostol for medical abortion up to 63 days' gestation...
Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture modelP G L Lalitkumar
Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, S 171 76, Stockholm, Sweden
Hum Reprod 22:3031-7. 2007..This study investigates the effect of levonorgestrel and mifepristone on attachment of human embryos to an in vitro endometrial construct...
Perceptions of contraception, non-protection and induced abortion among a sample of urban Swedish teenage girls: focus group discussionsCaroline Thorsén
Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
Eur J Contracept Reprod Health Care 11:302-9. 2006..To explore the attitudes of teenage girls towards contraception and induced abortion in order to better understand underlying reasons for non-protection...
Mechanisms of action of mifepristone when used for emergency contraceptionKristina Gemzell-Danielsson
Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76, Stockholm, Sweden
Contraception 68:471-6. 2003....
Expressions of steroid receptors and Ki67 in first-trimester decidua and chorionic villi exposed to levonorgestrel used for emergency contraceptionChun Xia Meng
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Fertil Steril 91:1420-3. 2009....
Acceptability of home-use of misoprostol in medical abortionChristian Fiala
Division for Obstetrics and Gynaecology, Department of Woman and Child Health, Karolinska Hospital/Institute, S-171 76 Stockholm, Sweden
Contraception 70:387-92. 2004..Women should be offered this choice to allow more flexibility and privacy in their abortions...
Emergency contraceptionP G L Lalitkumar
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet WHO Collaborating Center, Karolinska University Hospital, Stockholm, Sweden
Best Pract Res Clin Endocrinol Metab 27:91-101. 2013..To increase efficacy future studies should focus on EC methods that target the endometrium...
An historical overview of second trimester abortion methodsMarc Bygdeman
Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Reprod Health Matters 16:196-204. 2008....
Teaching medical students gynaecological examination using professional patients-evaluation of students' skills and feelingsKjell Wånggren
Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Hospital Institute, Stockholm, Sweden
Med Teach 27:130-5. 2005..It is strongly recommended that this type of programme with professional patients should be used for teaching gynaecological examination techniques to medical students...
Measurement of nitric oxide in the vaginaAngelos Sioutas
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Acta Obstet Gynecol Scand 87:1055-9. 2008..The objective of this study is to measure NO gas directly in the vaginal lumen of healthy women and in patients with vaginitis...
The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometriumXiaoyan Qiu
Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden
Mol Hum Reprod 8:998-1004. 2002..Our findings provide further insight into the regulation of IGFBP-1 and prolactin by PR in the human endometrium in vivo...
Emergency contraception: potential role of ulipristal acetateKristina Gemzell-Danielsson
Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
Int J Womens Health 2:53-61. 2010....
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS)Oskari Heikinheimo
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
Acta Obstet Gynecol Scand 91:3-9. 2012..Further studies are needed to examine the full potential of the LNG-IUS in such common clinical situations...
Emergency contraception with mifepristone and levonorgestrel: mechanism of actionLena Marions
Department of Women and Child Health, Karolinska Hospital, Stockholm, Sweden
Obstet Gynecol 100:65-71. 2002..To study the effect of mifepristone and levonorgestrel on ovarian function and endometrial development in doses effective as emergency contraception...
Effects of misoprostol on uterine contractility following different routes of administrationA Aronsson
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute/Hospital, S-171 76 Stockholm, Sweden
Hum Reprod 19:81-4. 2004..CONCLUSIONS: Based on recording of uterine activity, sublingual misoprostol acts as rapidly as oral treatment, while development of contractions was similar to that seen following vaginal administration...
Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effectsO S Tang
Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong SAR, China
Int J Gynaecol Obstet 99:S160-7. 2007..These studies can help to discover the optimal dose and route of administration of misoprostol for individual clinical applications. Misoprostol is a safe drug but serious complications and teratogenicity can occur with unsupervised use...
Effects of slow release misoprostol on uterine contractility in early pregnancyC Fiala
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Stockholm, Sweden
Hum Reprod 20:2648-52. 2005..CONCLUSIONS: SR misoprostol acts less on uterine tonus than orally administered conventional misoprostol but leads to development of regular uterine contractions...
Treatment of incomplete abortion and miscarriage with misoprostolJ Blum
Gynuity Health Projects, New York, NY 10010, USA
Int J Gynaecol Obstet 99:S186-9. 2007..A single dose of misoprostol 600 microg oral is recommended for treatment of incomplete abortion in women presenting with a uterine size equivalent to 12 weeks gestation...
Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparisonA Aronsson
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute, S-171 76 Stockholm, Sweden
Contraception 69:165-9. 2004..It was shown that sublingual administration is more effective than oral administration of misoprostol for cervical priming and is associated with less blood loss but a higher frequency of side effects...
Pharmacokinetics of a novel oral slow-release form of misoprostolC Fiala
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
Hum Reprod 20:3414-8. 2005..The pharmacokinetics of a novel slow-release (SR) misoprostol was studied and compared to conventional misoprostol...
The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestationC Fiala
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Clinical Epidemiology Unit, Karolinska Institute, 171 76 Stockholm, Sweden
Hum Reprod 20:3072-7. 2005....
Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and FranceW H Clark
Gynuity Health Projects, New York, USA
Eur J Contracept Reprod Health Care 10:184-91. 2005..Further research to determine if two doses of misoprostol are more effective than a single dose would be useful...
Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostolA Aronsson
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska University Hospital, Karolinska Institutet, SE 171 76 Stockholm, Sweden
Hum Reprod 22:1912-8. 2007..No study has so far evaluated the pharmacokinetics beyond 6 hours. Furthermore a new slow-release misoprostol formulation was included in the study...
Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trialI Sääv
Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
Hum Reprod 22:2647-52. 2007..However, insertion of an IUD through a narrow cervix may be technically difficult. Misoprostol has been shown to be effective for cervical priming in non-pregnant women prior to hysteroscopy...
Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeksP C Ho
Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong Special Administrative Region, China
Int J Gynaecol Obstet 99:S178-81. 2007..Common side effects of misoprostol-induced termination of pregnancy include gastrointestinal side effects, abdominal cramps, bleeding, fever and chills. Complications may include infection or rarely rupture of uterus...
Misoprostol to treat missed abortion in the first trimesterK Gemzell-Danielsson
Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
Int J Gynaecol Obstet 99:S182-5. 2007..Bleeding may last for more than 14 days with additional days of light bleeding or spotting. The woman should be advised to contact a provider in case of heavy bleeding or signs of infection. A follow-up is recommended after 1 to 2 weeks...
Cervical priming with misoprostol prior to transcervical proceduresC Fiala
Gynmed Clinic, Vienna, Austria
Int J Gynaecol Obstet 99:S168-71. 2007..Higher doses or longer intervals do not improve the effect on the cervix. Pain is a frequent side effect, but usually responds well to NSAIDs. Other side effects are rare...
Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe servicesR J Gomperts
Women on Waves, Amsterdam, The Netherlands
BJOG 115:1171-5; discussion 1175-8. 2008..8% of the women who did the medical TOP at home needed a vacuum aspiration. Telemedicine can provide an alternative to unsafe TOP. Outcomes of care are in the same range as TOP provided in outpatient settings...
